Protein Derivatives and Yeast Extract Group
Information sheet
These substances were identified for action under the Chemicals Management Plan (CMP). The screening assessment focuses on 4 substances referred to collectively under the CMP as the Protein Derivatives and Yeast Extract Group.
| Substance group | CAS RN | Common name | DSL name | Public comments on the draft screening assessment | Final screening assessment | Conclusion on section 64 criteria | Follow-up activities |
|---|---|---|---|---|---|---|---|
| Protein Derivatives and Yeast Extract Group | 8013-01-2Table 1 footnote a | Yeast extract | Yeast, ext. | HTML | HTML | Does not meet | None planned at this time |
| 9015-54-7Table 1 footnote a,Table 1 footnote b | Not available | Protein hydrolyzates | |||||
| 92113-31-0Table 1 footnote a,Table 1 footnote b | Collagen hydrolyzates | Collagens, hydrolyzates | |||||
| 111174-63-1Table 1 footnote a | Isostearoyl hydrolyzed collagen | Protein hydrolyzates, leather, reaction products with isostearoyl chloride | |||||
| Date | Activity |
|---|---|
| October 1, 2022 | Publication of the final screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 156, No. 40. |
| February 6, 2021 | Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 155, No. 6. |